Bromocriptine for an acromegalic patient. Improvement in cardiac function and carpal tunnel syndrome.
A 64-year-old woman with active acromegaly of 33 years' duration, severe carpal tunnel syndrome, and subclinical heart disease was treated with bromocriptine mesylate. Within eight months of therapy, basal growth hormone (GH) levels decreased from 90.0 to 7.0 ng/mL, and hand volume was reduced from 375 to 295 mL. Concomitantly, echocardiographic studies showed normal left ventricular size and function. Electromyographic studies demonstrated normal function in both median nerves. Bromocriptine may correct cardiac dysfunction and carpal tunnel syndrome in acromegaly either by reduction of GH oversecretion or by a direct effect of bromocriptine on dopamine receptors in the heart and peripheral nerve endings.
D000172:Acromegaly / Q000188:drug therapy*; D001971:Bromocriptine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002349:Carpal Tunnel Syndrome / Q000188:drug therapy*; D004452:Echocardiography; D004576:Electromyography; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006227:Hand Deformities, Acquired / Q000188:drug therapy; D006801:Humans; D008475:Median Nerve / Q000187:drug effects; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D013318:Stroke Volume / Q000187:drug effects; D014459:Ulnar Nerve / Q000187:drug effects
D001971:Bromocriptine; D013006:Growth Hormone